Calista GmbH acquired by BTL Industries, strengthening position in Swiss aesthetic medicine market

BTL Industries is pleased to announce the successful acquisition of Calista GmbH, a leading distribution company in Switzerland specializing in aesthetic medicine.

BTL and Calista have a long and successful business relationship. This strategic acquisition significantly strengthens our position in the Swiss market and gives us extensive direct access to a wide range of customers, enabling us to achieve greater market penetration.

Luc Joosen, founder and CEO of Calista, expressed his enthusiasm: “We are very excited to join forces with BTL. We respect BTL as one of the most innovative companies and market leaders in non-invasive treatments, the fastest growing segment in medicine. With BTL on board, Calista will be able to expand the product range of its portfolio more rapidly and enjoy a higher level of support”.

“The acquisition of Calista is the next milestone in our systematic approach to strengthen our position as the world’s leading manufacturer of medical and aesthetic devices with the most extensive network of direct global offices. Together we will be able to provide even better service and support to our customers,” commented Martin Petivoky, M&A Director at BTL.

This acquisition marks a significant step forward for both BTL Industries and Calista GmbH, promising enhanced services, expanded product offerings, and greater market reach.